Super Methotrexate-resistant Osteosarcoma Cells Retain Their Sensitivity to Recombinant Methioninase: Targeting Methionine Addiction to Overcome Extreme Cancer-Chemotherapy Resistance
Anticancer Research · 2025
DOI: 10.21873/anticanres.17480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yusuke Aoki und 7 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc, San Diego, CA, U.S.A.; yaoki0630@gmail.com. Hauptthemen laut MEDLINE: Methotrexate, Carbon-Sulfur Lyases, Osteosarcoma, Methionine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AntiCancer Inc, San Diego, CA, U.S.A.; yaoki0630@gmail.com.
- Department of Surgery, University of California, San Diego, La Jolla, CA, U.S.A.
- Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
- AntiCancer Inc, San Diego, CA, U.S.A.
- Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan yastome@med.u-ryukyu.ac.jp.
- AntiCancer Inc, San Diego, CA, U.S.A.; all@anticancer.com.
Zitieren
APA
Aoki, Y., Han, Q., Kubota, Y., Masaki, N., Tome, Y., Bouvet, M., Nishida, K., & Hoffman, R. M. (2025). Super Methotrexate-resistant Osteosarcoma Cells Retain Their Sensitivity to Recombinant Methioninase: Targeting Methionine Addiction to Overcome Extreme Cancer-Chemotherapy Resistance. Anticancer Research. https://doi.org/10.21873/anticanres.17480
Vancouver
Aoki Y, Han Q, Kubota Y, Masaki N, Tome Y, Bouvet M, et al. Super Methotrexate-resistant Osteosarcoma Cells Retain Their Sensitivity to Recombinant Methioninase: Targeting Methionine Addiction to Overcome Extreme Cancer-Chemotherapy Resistance. Anticancer Research. 2025. doi:10.21873/anticanres.17480
BibTeX
@article{Aoki2025,
author = {Aoki, Yusuke and Han, Qinghong and Kubota, Yutaro and Masaki, Noriyuki and Tome, Yasunori and Bouvet, Michael and Nishida, Kotaro and Hoffman, Robert M},
title = {Super Methotrexate-resistant Osteosarcoma Cells Retain Their Sensitivity to Recombinant Methioninase: Targeting Methionine Addiction to Overcome Extreme Cancer-Chemotherapy Resistance},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17480}
}
EUVIMED